Maze Therapeutics (MAZE) Net Margin (2024 - 2026)
Maze Therapeutics' Net Margin was -121.04% in Q1 2026.
Powered by 
Analysis
Maze Therapeutics (MAZE) Net Margin (2024 - 2026) Analysis & Trends
For FY2024, Net Margin at Maze Therapeutics came in at 2.03%.
- The Q1 2026 figure marks the highest quarterly Net Margin since Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.76 Bn | 1,104.34 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.07 Bn | 537.60 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.11 Bn | 476.22 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.23 Bn | 324.61 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.76 Bn | 262.75 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.14 Bn | 234.83 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.54 Bn | 192.94 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.65 Bn | 165.84 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.26 Bn | 116.90 Bn | 10.94 Bn | -1.65% |
| 10 | Maze Therapeutics | 1.93 Bn | 442.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -121.04% |
| Sep 30, 2024 | -990.08% |
| Jun 30, 2024 | 8.41% |
API Access
Maze Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=MAZE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "MAZE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=MAZE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();